Uncategorised

Adelaide, Australia, 21st September 2022 - GPN Vaccines is pleased to announce publication of a landmark scientific paper in the prestigious journal mBio showing its novel pneumococcal vaccine, Gamma-PN, elicits a broad-spectrum, serotype-independent opsonophagocytic antibody response. This research, conducted in collaboration with the University of Adelaide,...

Protecting children and adults from the world’s foremost bacterial pathogen